Crystal structure of an extracellular superoxide dismutase from Onchocerca volvulus and implications for parasite-specific drug development
- PMID: 35647680
- PMCID: PMC9158661
- DOI: 10.1107/S2053230X22005350
Crystal structure of an extracellular superoxide dismutase from Onchocerca volvulus and implications for parasite-specific drug development
Abstract
Superoxide dismutases (SODs) are metalloproteins that are responsible for the dismutation of superoxide anion radicals. SODs are consequently protective against oxidative damage to cellular components. Among other protective mechanisms, the filarial parasite Onchocerca volvulus has a well developed defense system to scavenge toxic free radicals using SODs during migration and sojourning of the microfilariae and adult worms in the human body. O. volvulus is responsible for the neglected disease onchocerciasis or `river blindness'. In the present study, an extracellular Cu/Zn-SOD from O. volvulus (OvEC-SOD) was cloned, purified and crystallized to obtain structural insight into an attractive drug target with the potential to combat onchocerciasis. The recombinant OvEC-SOD forms a dimer and the protein structure was solved and refined to 1.55 Å resolution by X-ray crystallography. Interestingly, a sulfate ion supports the coordination of the conserved copper ion. The overall protein shape was verified by small-angle X-ray scattering. The enzyme shows a different surface charge distribution and different termini when compared with the homologous human SOD. A distinct hydrophobic cleft to which both protomers of the dimer contribute was utilized for a docking approach with compounds that have previously been identified as SOD inhibitors to highlight the potential for individual structure-based drug development.
Keywords: Cu/Zn superoxide dismutases; Onchocerca volvulus; X-ray crystallography; docking; drug targets; metal ion coordination; parasites.
open access.
Figures



Similar articles
-
Functional characterization and immune recognition of the extracellular superoxide dismutase from the human pathogenic parasite Onchocerca volvulus (OvEC-SOD).Acta Trop. 2012 Oct;124(1):15-26. doi: 10.1016/j.actatropica.2012.05.013. Epub 2012 Jun 4. Acta Trop. 2012. PMID: 22677600
-
Molecular cloning of an Onchocerca volvulus extracellular Cu-Zn superoxide dismutase.Infect Immun. 1994 Feb;62(2):713-6. doi: 10.1128/iai.62.2.713-716.1994. Infect Immun. 1994. PMID: 8300230 Free PMC article.
-
Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo.PLoS Negl Trop Dis. 2022 May 3;16(5):e0010340. doi: 10.1371/journal.pntd.0010340. eCollection 2022 May. PLoS Negl Trop Dis. 2022. PMID: 35503786 Free PMC article.
-
Advancing a Human Onchocerciasis Vaccine From Antigen Discovery to Efficacy Studies Against Natural Infection of Cattle With Onchocerca ochengi.Front Cell Infect Microbiol. 2022 Apr 4;12:869039. doi: 10.3389/fcimb.2022.869039. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35444961 Free PMC article. Review.
-
CD4+-dependent immunity to Onchocerca volvulus third-stage larvae in humans and the mouse vaccination model: common ground and distinctions.Int J Parasitol. 2003 Sep 30;33(11):1161-71. doi: 10.1016/s0020-7519(03)00170-x. Int J Parasitol. 2003. PMID: 13678632 Review.
References
-
- Ascone, I., Castañer, R., Tarricone, C., Bolognesi, M., Stroppolo, M. E. & Desideri, A. (1997). Biochem. Biophys. Res. Commun. 241, 119–121. - PubMed
-
- Assfalg, M., Banci, L., Bertini, I., Turano, P. & Vasos, P. R. (2003). J. Mol. Biol. 330, 145–158. - PubMed
-
- Banci, L., Bertini, I., Hallewell, R. A., Luchinat, C. & Viezzoli, M. S. (1989). Eur. J. Biochem. 184, 125–129. - PubMed
-
- Basáñez, M.-G., Pion, S. D., Boakes, E., Filipe, J. A., Churcher, T. S. & Boussinesq, M. (2008). Lancet Infect. Dis. 8, 310–322. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources